Family history does not appear to increase risk of prostate cancer progression, analysis reveals

NewsGuard 100/100 Score

Active surveillance-careful monitoring to determine if or when a cancer warrants treatment-is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is appropriate for men with a family history of prostate cancer. A recent analysis of the medical literature concluded that a family history of prostate cancer does not appear to increase a patient's risk of having more aggressive prostate cancer.

In the analysis, six studies found that family history does not appear to increase the risk of prostate cancer progression, while one study found that family history may increase the risk of prostate cancer progression only in African Americans.

"Our results suggest that having a family history of prostate cancer should not automatically exclude men from being considered for active surveillance treatments, although some questions remain about risks for African American men with a family history of prostate cancer," said Dr. Jim Dupree, senior author of the BJU International review. "Men obviously need to have thorough conversations with their doctors about risks, benefits, and options, and more research needs to be done to confirm these findings, especially among African American men."

Comments

  1. Larry Glickman Larry Glickman Colombia says:

    Associative studies are quite popular and yet logically they merely present odds and not cause and effect in the individual case. A study some years ago by Joe De Risi the acclaimed scientist in his San Francisco laboratory showed that a missing enzyme that suppresses viruses correlated to the prostate cancer he was finding in samples he used to test his sophisticated device that can spot any virus from one tissue sample. (Available for viewing on the TED network online) My point is that a test showing a familial lack of this enzyme  is a real biological linkage and that type of group needs to be tested for progression evidence not a random large group with varied biological backgrounds and profiles.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breast Cancer Now funds new research to investigate how breast cancer cells survive and grow